Canada markets closed

Tonghua Dongbao Pharmaceutical Co., Ltd. (600867.SS)

Shanghai - Shanghai Delayed Price. Currency in CNY
Add to watchlist
10.08+0.05 (+0.50%)
At close: 03:00PM CST

Tonghua Dongbao Pharmaceutical Co., Ltd.

Dongbao New Village
Tonghua County
Tonghua 134123
China
86 43 5508 8025
https://www.thdb.com

Sector(s)Healthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees3,196

Key Executives

NameTitlePayExercisedYear Born
Mr. Sheng Leng ChunChairman & GMN/AN/A1974
Mr. Junyu ChiChief AccountantN/AN/A1979
Mr. Hong ChenChief Engineer and Deputy General ManagerN/AN/A1974
Mr. Guodong ZhangDeputy GM & DirectorN/AN/A1976
Mr. Wenhai ZhangDeputy GM & DirectorN/AN/A1974
Mr. Zhiqiang DuDeputy General ManagerN/AN/A1972
Ms. Fan SuDeputy GM & Board SecretaryN/AN/A1979
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China. The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments. It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices. Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system. It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Corporate Governance

Tonghua Dongbao Pharmaceutical Co., Ltd.’s ISS Governance QualityScore as of May 1, 2024 is 2. The pillar scores are Audit: 7; Board: 6; Shareholder Rights: 2; Compensation: 1.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.